W.Va. local governments get 24.5% of opioid settlement funds, but the oversight and how the funds are spent varies

Graph by Hannah Heiskell, data from West Virginia First Memorandum of Understanding 

In 2021, West Virginia lost more than one thousand residents due to opioid overdose deaths. Between 2021 and 2024, the state ramped up its prevention and treatment efforts, some of which now benefit from opioid settlement dollars. As investigative student reporters from West Virginia University’s Reed School of Media discovered, how those funds are spent varies widely throughout the state.

"West Virginia will receive about $980 million from the settlement, split into payments over 18 years," reports Hannah Heiskell for Mountain State Spotlight. "The West Virginia First Foundation – a nonprofit created by the state Legislature – will control the spending of 72.5% of the funds, local governments 24.5%, and the West Virginia Attorney General’s Office 3%."

How local governments spend their chunk of settlement funds is limited by state guidance, but includes "increasing access to treatment or prevention-education programs."

With those constraints in mind, WVU student reporters looked at "how local governments oversee that money, including the process through which they take applications, make awards and account for spending," Heiskell explains. Since each local government can make its own decisions, "oversight and accountability built into local spending can be markedly inconsistent from county to county – with some doing very little to collect the advice and opinions of addiction experts or people with lived experience."

Local funding is often decided by county commissioners, who are not subject to the oversight by the West Virginia First Foundation. "While county commissioners are not required to have expertise in substance use disorders or follow a specific application, review, or awarding process, Laura Lander, addiction therapist and associate professor at West Virginia University’s Rockefeller Neuroscience Institute, said this thinking confused her," Heiskell reports.

"Without input from external sources and stakeholders, Lander said funding awards are subject to a commissioner’s individual bias," Heiskell writes. Lander told her, "Clearly, in other counties, based on what I’ve seen, the money used for law enforcement has the county commissioner’s ear, and we see lots of money going towards police vehicles."

Kanawha County Commission has opted to share some details by "posting all applications to their website for the public and other organizations to review," Haskell writes. "In contrast to many counties in the state, the Preston County Commission has taken a more deliberate approach to its spending. . . . It's one settlement and 55 systems."

Proposed $7 billion Purdue settlement advances; leaves Sacklers exposed

Adobe Stock photo

Since last July when the U.S. Supreme Court rejected the Purdue Pharma opioid bankruptcy agreement, negotiation has continued. The latest offer from the Sackler family may have enough support from stakeholders to stick.

"OxyContin maker Purdue Pharma’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it," reports Geoff Mulvihill of The Associated Press. U.S. Bankruptcy Court Judge Sean Lane "is being asked to clear the way for local governments and individual victims to vote on it next."

If Lane moves the agreement forward, impacted parties have until Sept. 30 to vote "on whether to accept the deal, which calls for members of the Sackler family who own the company to pay up to $7 billion over 15 years," Mulvihill explains. Roughly $6.5 billion of the settlement will be taken from the Sackler's wealth, and "potentially more than $850 million would go directly to individual victims."

The biggest change the reworked plan offers is that it does not guard Sackler family members from civil liability suits related to the opioid crisis. Groups that reject this settlement can continue litigation against Sackler family members. Mulvihill adds, "Under the plan, the Sackler family members would give up ownership of Purdue."

The $7 billion the Sacklers have put on the table pales in comparison to their exposure. Mulvihill reports, "The settlement is a way to avoid trials with claims from states alone that total more than $2 trillion in damages. Thousands of local governments and other groups have also sued Purdue."

While the settlement is an attempt to hold the Sackler family accountable for its part in the prescription drug crisis, the family will remain exceptionally wealthy and will continue to run its global pharmaceutical company, Mundipharma, which operates in the United Kingdom, Canada, Germany and Singapore. 

Microgrant deadline extended for reporting on opioid settlement funds

Reporting on Addiction, a collaborative movement staffed by media professionals working to address addiction, is extending its deadline to apply for 2025 microgrants for journalists reporting on opioid settlement funds in Kentucky, Maine, New Jersey or New York.

June 20 is the new deadline. Apply here.

As billions in opioid settlement funds enter the U.S. economy, how that money will be spent is unclear. Especially for individuals, families and communities touched by the opioid and fentanyl crisis, having journalists who use their investigative skills to follow who spends the money and on what is of vital importance. Watchdog reporters are needed as a primary, trustworthy source for people who want to hold public officials accountable for how these funds are used to address the addiction crisis.

To support this vital journalistic effort, Open Society Foundations is partnering with Reporting on Addiction to offer four microgrants ($500–$1,000 each) for journalists reporting in Kentucky, Maine, New Jersey and New York to investigate how opioid settlement funds are being allocated and spent.

Grants will support long-term reporting that help your audience understand the opioid settlements and show them where and how funds are being spent. Priority will be given to submissions focused on:

• Spending (or a lack of spending) related to evidence-based prevention, addiction, harm reduction, treatment and/or recovery.
• Issues with waste, fraud, abuse, or mismanagement of opioid settlement funds.
• Incorporating the perspectives of impacted community members.
• Helping communities understand the spending decision-making process (or lack of process).

Story pitch requirements: Pitches can be for any platform, print, digital, radio, television, podcast, etc. Freelancer submissions are welcome, but must have a letter of support from a publisher.

Grant awardees will receive free training: Awardees must agree to attend two virtual Reporting on Addiction trainings, share their final story, and have a commitment from a newsroom editor to publish their reporting by Feb. 1, 2026. Freelancers should secure a publication commitment before applying and supply supporting documentation.

A rural jail has success curbing opioid addictions: 'Jails are an incredible opportunity to help people enter recovery'

Alane O'Connor, DNP

Developing an effective and repeatable treatment for addiction sufferers has proven elusive -- until now. A rural jail in Maine has a solution that could save thousands of lives.

Addiction medicine specialist Alane O’Connor is leading a pilot program that "offers a monthly injection of the drug Sublocade to addicted inmates," reports Kristina Samulewski of The New York Times. The drug works through a time-release mechanism that curbs opioid cravings for a month. O'Connor presents her case for jails as drug recovery centers on the Times' podcast, "The Opinions." An edited synopsis of her discussion is shared below.

The state of Maine is overwhelmingly rural. It also has "one of the highest rates of opioid use disorder in the nation. And people who are incarcerated have an even higher rate, because often times the two go in tandem," O'Connor explains. "Jails are an incredible opportunity to help people enter recovery. It’s a time where motivation is often very high, but I think we don’t do a very good job, really, across the country in giving people access to the treatment that they need."

In response to the opioid epidemic's extreme reach in Maine, O'Connor suggested that Somerset County Jail try a different approach for treating inmates with opioid addictions. "I proposed an alternative medication, which I had been using in my community practice since 2017," O'Connor adds. "It’s not a pill. It’s actually an injection into the abdomen, and it’s called Sublocade."

Sublocade is gradually and continuously released into a recovering addict's system. Other opioid drug treatments can include daily methadone and/or Suboxone pills, which people can opt not to take. Sublocade does not offer a choice.

"If I have a patient that I’m prescribing Suboxone to and they don’t have that medication tomorrow or the next day, they are going to get very sick," O'Connor explains. "Sublocade slowly dissolves out of the system, and so patients will start to feel some symptoms after five or six weeks. But there isn’t this cliff that ends where people get very, very sick."

O'Connor says, "I’ve never, ever met anyone who said, I want to grow up and be addicted to drugs and end up in jail. It’s just not a reasonable thing to even think. And yet, I think society believes that patients can just make the choice to stop using tomorrow. And if they don’t have the appropriate medical treatment, that’s just a totally unreasonable expectation."

When Somerset County Jail's Sublocade treatment results were compared with another rural Maine jail where inmates received a daily pill of Suboxone, the results were striking. O'Connor notes, "We found that people treated with Sublocade were almost three times as likely to continue treatment when they leave the jail, relative to folks who were treated with the daily medication. . . . The most important finding was that we had no deaths in the people that were treated in the Sublocade pilot . . . In the comparison jail, unfortunately, there were four deaths."

A simpler assessment tool for newborns exposed to opioids means more mom time and fewer medications

Cailyn Morreale continued using buprenorphine during her pregnancy. Once her baby was born, the two were never separated. (Photo by Taylor Sisk, KFF Health News)

A new approach is helping mothers recovering from opioid addiction and newborns with opioid exposure stay together after birth. Historically, babies born with opioid exposure have been separated from their mothers and received heavy medications in neuro-intensive units, but "research has since indicated that in many, if not most, cases, those extreme measures are unnecessary," reports Taylor Sisk of KFF Health News. "A newer, simpler approach that prioritizes keeping babies with their families called Eat, Sleep, Console is being increasingly embraced."

Over the past decade, how pregnancy pairs with addiction treatment has changed, meaning most women can continue to take addiction-recovery medication throughout pregnancy. For Cailyn Morreale, a West Virginian from rural Mars Hill, the new methods helped her continue her recovery medicine, buprenorphine, and her care team assured her "that her baby would be assessed and monitored using the Eat, Sleep, Console approach," Sisk explains. "Morreale was never separated from her son. She was able to begin breastfeeding immediately. She was told, the trace of buprenorphine in her breast milk would help her son withdraw from it."

The Eat, Sleep, Console method is slowly replacing the older Finnegan Neonatal Abstinence Scoring System, which involved 21 evaluative questions. Sisk writes, "David Baltierra, former director of West Virginia University’s Rural Family Medicine Residency Program, chair of WVU’s Department of Family Medicine, suggests this protocol could simply be called 'parenting.' Baltierra and his colleagues have been training residents to use an Eat, Sleep, Console approach for a decade. . . .The results are persuading more health professionals to adopt the method."

A 2023 study found "babies treated this way were discharged from the hospital in nearly half the time and less likely to receive medication than those receiving Finnegan-based care," Sisk reports. "Matthew Grossman, an associate professor of pediatrics at the Yale School of Medicine, found a non-pharmacological-first approach works best. He said the Finnegan tool is useful but often too rigid. Under its scoring, one sneeze too many could send a baby to the NICU for weeks."

Research by Leila Elder and Madison Humerick, who each did their residency in WVU’s rural program, "found that median stays for newborns in withdrawal dropped from 13 days in 2016 to three in 2020," Sisk adds. "The simpler treatment also means more babies born in rural communities can receive care closer to home and has reduced the likelihood a mother will be released before her baby is cleared to go home."

A young farmer and former addict offers hope for recovery: 'The only thing you’re not coming back from is death.'

Nathan Caburn, a successful Mississippi Delta farmer
and past opioid addict. (Photo by C. Bennett, Farm Journal)

Nathan Casburn could be a poster child for a drug-addicted prodigal son, who threw away his farm and family for oxycontin and heroin highs.

Casburn's story is a tale that resonates with opioid-ravaged families and reflects what the love of a father and the support of a rural community can do for addicts who want to go home and begin again, writes Chris Bennett of Farm Journal. "Casburn is a most unlikely survivor. He tells a hellish tale of loss and triumph on the farm — without a shred of blame cast beyond his own shadow."

As a teenager, Casburn obsessively played video games. He told Bennett, "I played every waking moment I could, to the point of fixation. I knew I was different from the other kids and not in a good way; I was geared toward escapes. In my case, an obsession with video games was a symptom of my unhealthy mindset.”

From video game escapes, Casburn went on to alcohol. Bennett writes, "In 2004, on backroad gravel, Casburn, a high school junior, broke two vertebrates in an alcohol-related car crash. The subsequent pain management became a party, legitimized by medical approval in the age of OxyContin. Casburn was in love. Welcome to the wonder world of opioids."

Casner wanted nothing to do with his family's Mississippi Delta farm in Tallahatchie County. He was all about the highs. "Next stop, 75 miles west to Ole Miss and Oxford, and a chain of descent in a college town: DUI’s, car wrecks, arrests, hospitalization, overdoses, academic probation, and legal woes," Bennett explains. "By 2014, with no job, no degree, and no prospects. . . . OxyContin and other legal pharmaceuticals were out of his price range. He responded with the most hellish economic decision of his life. Go home to the farm and tap the vein. Heroin."

"Rain or shine, addiction woke Casburn at dawn every day, demanding a morning fix," Bennett writes. "In 2017, at 29, Casburn’s body gave out. After two weeks in intensive care due to a heart valve infection derived from heroin use, he returned home, and checked into rehab. . . . Three weeks after rehab, Casburn was back on the needle."

Then death came knocking. Casburn told Bennett: "I had an out-of-body experience with no drugs involved. I saw everyone going on with life, and me stuck right there dying as an addict. Right then, in the library, I dropped to my knees and threw up a prayer in desperation, but I meant every word. I called out to God for mercy and forgiveness. I told Him that if He would help me, then I’d do everything He asked. That prayer was answered.”

He told Bennett, “All the people around me in our farming community came to help me in one way or another." Bennett adds, "Seven years after crashing to his knees, Casburn has earned a stellar reputation and built a thriving farm life. . . . In March 2024, he and his wife Caitlin were blessed with a baby girl — Nora." He is grateful for a "particularly stalwart source of support — his father, Rea."

Casburn wants people who are addicted to know there is always hope. He told Bennett, "Never, never believe that you can’t get out of drugs. You’re never too far gone. The only thing you’re not coming back from is death.”

Opinion: Understanding how fentanyl 'saturated the U.S. drug supply' could help address the addiction crisis

Naloxone can prevent overdose deaths, but it's expensive.
(Adobe Stock photo)

The current U.S. opioid crisis started with painkiller prescriptions in the early 2000s, but once medical providers started nixing those medicines, heroin's popularity surged, and then fentanyl and its "tsunami" of death entered the market, reports Maia Szalavitz of The New York Times. "Understanding how fentanyl saturated the drug supply, moving from the East Coast of the U.S. to the West, is critical to ending the worst drug crisis in American history."

Drug cartels' greed drove the creation and use of fentanyl. "By 2013, cartels had realized that they could slash their labor, manufacturing and transit costs by replacing heroin derived from farm-grown opium with a powder made in a lab — fentanyl," Szalavitz writes. "Before 2018, 80% of all deaths associated with fentanyl occurred east of the Mississippi. . . . Since 2021, at least two-thirds of America’s 100,000 annual overdose deaths involved a synthetic opioid like fentanyl."

While heroin was considered a more urban drug, "increased opioid prescriptions — followed by sharp reductions — resulted in new heroin users in rural areas," Szalavitz explains. "Illegally manufactured fentanyl began appearing in both urban and rural drug markets. . . . Rural West Virginia and other Appalachian regions were the center of the earliest prescription opioid wave of the crisis, which led to the establishment of new heroin markets in places facing job loss."

Combating opioid addiction and overdose deaths liked to fentanyl is tough because the drug's supply chain and use is now deeply embedded across the country. The drug is cheap to make and buy, and provides an exceedingly potent high for the user. "So, what can be done? The answer is to focus on the drivers of demand, not supply. This means addressing the roots of addiction and treating it compassionately," Szalavitz writes. "We have a great generic opioid overdose antidote, naloxone. . . . And two medications — methadone and buprenorphine — have proved to cut the risk of death among people with opioid addictions by 50% or more when used long-term."

Szalavitz adds that people often start doing drugs because their lives feel hopeless. "Addiction is most often an attempt to escape despair. The condition itself is defined by compulsive drug use despite negative consequences, which is why threats of punishment or even death rarely yield recovery. . . . It’s not coincidental that the exponential rise in overdose deaths has occurred in tandem with a profound increase in income inequality."

Rural jail offers newly released prisoners with addiction disorders a long-lasting drug to prevent relapse

Cost is a major barrier to using Sublocade as an
addiction treatment for prisoners. (Adobe Stock photo)

In rural Maine, a county jail began giving a long-lasting form of buprenorphine to inmates with drug addictions before they left incarceration. The medicine, which curbs opioid cravings for 28 days, helps past inmates avoid "withdrawal, relapse and overdose — dangers that newly released prisoners confront nationwide," reports Jan Hoffman of The New York Times.

Once out of jail, addiction sufferers can face several obstacles to staying in recovery while re-entering their communities. Maine's Somerset County sheriff, Dale P. Lancaster, was discouraged by the number of inmates who would leave prison and die from overdoses. Lancaster pushed for the extended-release medical treatment. Hoffman writes, "According to a recent analysis in Health and Justice, the switch had a remarkable effect. The long-acting injection afforded newly released prisoners a crucial buffer period after they were discharged, with more time to set up continuing addiction treatment and stabilize their lives."

People suffering from drug addictions are more likely to end up on the wrong end of the judicial system. "Of the more than 1.2 million prisoners in the United States, up to 65 percent of prisoners have active substance use disorders, according to some studies," Hoffman explains. And while those institutions have an opportunity to treat the addicted, few have the resources or staffing. In the case of extended-release shots of buprenorphine, known as Sublocade, the treatment's cost remains a big barrier, with the list price for a monthly injection about $2,000, while a month's supply of pills ranges from $90 to $360.

But the success of Maine's program may help turn the tide. "After being released, the Somerset County prisoners who got the shot were three times as likely to continue treatment as those at another rural Maine jail who received the daily pills" [which are discontinued upon release], Hoffman adds. "Between September 2022 and September 2023, three prisoners from the jail where the pills were dispensed died from overdoses within three months of being released; a fourth died by suicide. None of the former Somerset prisoners who had received the injections died."

Dr. Alane O’Connor, co-chair of Maine's Opioid Response Clinical Advisory Committee, said that "as word of the Somerset program spreads, she is getting inquiries from other county sheriffs about how to bring the shots on board," Hoffman reports. "She is also hearing from former prisoners." O'Connor told Hoffman, "Many wanted to stay on the shots, so they would come back to the jail asking our help in finding a provider."

Appalachian program helps people in recovery find a new life in construction work

Lindsey King works on a new home.
(Photo by J. Glendenning, IRJ)

Lindsey King is rebuilding her life by building homes in Kentucky. Her new career is a testament to a successful trifecta of efforts from the Hazard-based Housing Development Alliance's Hope Building Program, the Perry County Drug Recovery Court, and King's determination, reports Jenni Glendenning of the Institute for Rural Journalism. King will celebrate four years of recovery on Aug. 18.

Like many people in recovery circles, King experienced a "moment of clarity" when she "was only able to see her children once during her six-month stay," Glendenning writes. "She praised Perry Circuit Judge Alison Wells, who sent her to treatment after her arrest. King told Glendenning, “She seen things in me far before I’ve seen them in myself, and she pushed me to get there.”

King attributes part of her ongoing successful recovery to community support. She told Glendenning, "There’s no stigma over recovery anymore around here." Glendenning writes, "When King entered the Hope Building Program as a trainee, she and her children, now 8 and 7, lived in a one-bedroom apartment with one twin bed and a small closet. She moved up to a two-bedroom apartment and now owns her own home, where they all have a bedroom, and the kids have a place to play outside."

King likened recovery to building a home, which starts with a solid foundation and goes up from there. "She knew she wanted to be a carpenter after about a month of being involved in the Hope Building Program, even though she had never done construction," Glendenning explains. "King said that she has not been treated differently on the job because she was a woman. . . . Her advice for women looking to enter the trade is, 'Even if it’s something you think you can’t do, do it, go for it!'"

To become a carpenter, King attended Hazard Community and Technical College and "is the first person in her immediate family to attend college," Glendenning reports. "After King completed the program, the HDA hired her as a temporary assistant trainer for a year. Now she is a full-time assistant to lead trainer Josh Boyd; they work with a crew of four in the program."

King with her children, Waylon and Iris
(Photo by J. Glendenning, IRJ)

The Hope Building Program is primarily funded by the Appalachian Regional Commission’s Just Transition Fund for coal counties. "It aims to increase the long-term success rates of people in recovery while also rebuilding the local housing market," Glendenning writes. Shannon Gabbard, who runs the Hope Building Program, told Glendenning, “Ultimately, our goal is to help them transition into the workforce full-time. They must consistently pass random drug screenings, and the feedback we can provide helps to ease the minds of employers who may otherwise hesitate to hire employees who are in recovery.”

A criminal record can make it hard for people in recovery to find employers willing to give them a chance. Glendenning explains, "The Hope Building program does a background check, but Gabbard tells trainees, 'I don’t want them to stress about it because we haven’t seen anything yet that we haven’t been able to work through.' This offers a sense of relief, but once they are hired, 'they cannot have any new criminal charges after they begin the program.'"

Mindy Miller, HDA’s director of development and communications, whose own family has seen hardship from the drug epidemic, told Glendenning, “It's stories like Lindsey’s that give people hope. Her story is a lighthouse, a beacon shining in the night for every addict and for every person out there who loves an addict." Glendenning adds, "King considers the folks at the HDA her family and loves knowing that through her work she is giving back to her community by building something that is going to be someone’s home."

Drug-use stigma among addiction treatment providers is a barrier to care; state policymakers can help create change

Many substance abuse disorder providers have stigmas
about drug use. (Photo by V.  Hryshchenko, Unsplash)

Even though many addiction treatment centers encourage participants to talk openly about their opioid or substance-use disorder, many patients encounter medical providers with drug-use stigmas, which present an obstacle to care, reports Kaitlyn Levinson of Route Fifty. Some state governments can use policy changes to help remove social stigmas as a barrier to addiction treatment.

Noa Krawczyk, an assistant professor at New York University, told Levinson, "At the individual level of a person choosing not to use those treatments because of negative perceptions around them, to the policies that regulate these treatments [and] to the protocols that exist in treatment programs for how these medications are delivered. . . .[Stigma is] ingrained in every single aspect of these treatments and plays a huge role as in terms of a barrier to care.”

Even when opioid treatment is available and affordable, facing a biased medical community can mean a substance disorder patient opts out of recovery treatment. "A recent analysis from The Pew Charitable Trusts suggests normalizing methadone treatment could help expand its accessibility," Levinson writes. "Some states are moving to align their methadone-related regulations to mirror the federal government’s efforts, including California where policymakers are considering a bill that would allow doctors — not just methadone clinics — to prescribe take-home doses of the medicine."

Making treatment more accepted and widely available may address some stigmas, but changing policy goals and language can also help shift attitudes.

Massachusetts policymakers are working to remove drug-use stigma dynamics when a newborn tests positive for drug dependency. "Under current law, hospital workers are required to notify state officials about babies whose blood tests indicate substance use from their parent," Levinson reports. "The new policy would only mandate such reporting if the infant was at imminent risk of abuse or neglect, WBUR reported. The bill also directs health officials to establish a plan for new parents managing their substance use disorder."

Addiction workers need to thoroughly understand addiction as a medical problem or many treatment facilities will fail to help patients. Frances McGaffey, associate manager of Pew’s substance use prevention and treatment initiative, told Levinson, "[Otherwise] there is a mismatch between the community the provider aims to serve and the population actually getting care."

Friday quick hits: Rural top-flick picks; dairy funds; heat can kill; racial voting division; bread debate; hop on a new train

Eita Okuno, Anna Sawai, and Hiromoto Ida in 'Shōgun.' (FX /IMDb image via The Daily Yonder)

On steamy days when the pool is too crowded and you can't handle any more of Mother Nature's energy-sucking heat, it might be time to chill indoors and take in a rural flick. From the "Mad Max Saga" to wrestling's fierce Von Erich family drama to the stunning "craftsmanship and costuming" in "Shōgun," Adam B. Giorgi of The Daily Yonder has some fine movie picks that will make relaxing in the AC much more fun.

In states with the highest number of drug overdose deaths, patients in treatment for mental illness often live with an opioid use disorder that mental health clinics are unable to treat, a study showed. "Despite high rates of opioid use disorder among people with mental health disorders, only a third of community outpatient mental health treatment facilities in 20 high-burden states offered medications for OUD," reports Shannon Firth of MedPage Today. "Among the 450 community outpatient mental health treatment facilities surveyed, weighted estimates showed that 34% offered medications for OUD, reported study co-author Jonathan Cantor, PhD. JAMA Network Open published the study in June.

Jersey Scoops capitalized on the USDA's new small
dairy initiative. (Jersey Scoops photo)

What's better than locally made ice cream or homestead cheeses? More of both. At least that's what the Department of Agriculture seems to think. The USDA is funding a new initiative that "aims to transform and diversify the dairy industry, one small producer at a time," reports Naoki Nitta of Civil Eats. "At 'Jersey Scoops' in Loleta, a small, unincorporated community in Northern California’s Humboldt County, the ice cream is as fresh as it gets. From pasture to parlor, its organic, butterfat-rich milk travels less than 10 miles, produced by a herd of Jerseys pasture-raised on the misty coast. . . . But Jersey Scoops didn’t get here on their own; they leveraged a $60,000 grant from the Pacific Coast Coalition’s Dairy Business Innovation Initiative to secure both the space and equipment." Learn about how local cheese ventures are leveraging this funding here.

As global temperatures continue to spike, awareness of heat-related illnesses is especially vital for outdoor workers and their employers. Heat can make workers sick, but it can also be deadly, reports Seth Borenstein of The Associated Press. "With much of the United States, Mexico, India and the Middle East suffering through blistering heat waves. . . several doctors, physiologists and other experts explained what happens to the human body in such heat." To find out how heat kills, click here.

Handmade bread is much different than mass produced
loaves. (Bluegrass Baking Company photo)

Bread is considered a U.S. family staple for affordable nutrition, but the processing that creates a uniform and stay-fresh loaf has landed "packaged bread in the middle of a fraught debate over 'ultra-processed food,'" reports Jesse Newman for The Wall Street Journal. "Less-processed foods tend to be more expensive and quicker to spoil. . . . For bakers like Jim Betts, owner of Bluegrass Baking Company in Lexington, Ky., most packaged bread is a far cry from the food that has been sustaining humanity for at least 10,000 years." To read why homemade bread is so dramatically different and more pricey than store-bought loaves, click here.

The U.S. rural-urban voter divide primarily exists among whites, a new study published in Politics, Groups, and Identities found. Kate Blackwood for PHYS.org reports, "When it comes to politics, Black and Latino residents of rural America differ far less, if at all, from their urban counterparts than do non-Hispanic white residents, the researchers report." One of the study's authors, Suzanne Mettler, told Blackwood, "Rural and urban Americans began moving apart politically in the late 1990s, and the division has widened and deepened since then. . .We wanted to know whether all Americans, regardless of race and ethnicity, are swept up in this growing cleavage.

A Borealis Amtrak train rounds the corner
surrounded by Midwestern fall colors. (Amtrak photo)

Midwestern states have been busy working to add more train services to their transportation portfolios. The new Amtrak Borealis service between Chicago and St. Paul opened last month after 12 years of planning, reports Daniel C. Volk of Route Fifty. "The new service was also a breakthrough. It is the first new passenger route launched in Minnesota since 1975, and the first in Wisconsin in more than two decades. . . . Officials in both states — like dozens of others across the country — are now planning for even more new passenger routes, because of incentives in President Joe Biden’s 2021 infrastructure law." Borealis trains include wide reclining seats, ample legroom, free Wi-Fi and views of the Mississippi River between St. Paul and La Crosse, Wisc., in daylight in both directions across Wisconsin.

'On the Front Porch' is hosting an expert-led discussion on July 8 about the opioid crisis in rural America

Tony Pipa and Brent Orrell are back "On the Front Porch" hosting rural-focused conversations starting on Monday, July 8, from 12:45 to 1:45 p.m. E.T.

Their July 8 event will include insights from Keith Humphreys, a professor at Stanford University, and Sally Satel, senior fellow at the American Enterprise Institute, both of whom are experts on opioid use disorder and its impact on rural communities. Their discussion will look at the causes of and potential solutions to the nation’s drug epidemic, especially as that challenge presents in nonmetropolitan areas.

Register here. If you have missed previous On the Front Porch conversations, you can find them here.

In other rural news, the second season of Pipa's Reimagine Rural podcast continues with new episodes every three weeks this summer. The most recent episode explores Licking County, OH, the future home of Intel’s two new semiconductor factories, which is the largest private sector investment in Ohio’s history. Pipa speaks with elected leaders of nearby jurisdictions about the inevitable changes they face and the collective planning process they developed to protect the integrity of their towns after being left out of the siting decision. You can listen to that episode here or on your favorite podcast platform.

Past episodes, including all of season 1 and the first three episodes of season 2, can be found here.